Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Peptide therapy uses peptides, which are small molecules made of amino acids—the building blocks of proteins. Peptides help cells communicate and regulate many body functions, including immune responses and inflammation. In cancer care, peptide therapy refers to treatments or supplements that use these molecules to support the body’s natural defenses, manage symptoms, or sometimes directly target cancer cells.
Some peptide therapies involve linking a radioactive substance to a peptide that specifically targets cancer cells. This approach, known as peptide receptor radionuclide therapy (PRRT), is used for certain tumors like neuroendocrine tumors. When injected, the radioactive peptide binds to cancer cells and delivers targeted radiation to help control tumor growth.
Peptide therapy is discussed in cancer care because peptides may influence immune signaling, inflammation, metabolism, and symptom relief. Some peptides are studied for their potential to directly attack cancer cells or support other treatments. Others may help improve quality of life by reducing symptoms or supporting recovery during or after conventional cancer treatments.
However, the evidence supporting peptide therapies varies widely. Some uses are well studied and approved, like PRRT, while many others remain experimental or investigational. Peptide therapies should not replace standard cancer treatments but may be considered as supportive care or part of clinical trials under medical supervision.
Patients may encounter peptide therapy in different ways. It might be mentioned as part of a treatment plan, in clinical trial information, or as a supplement or alternative approach. Peptides come from many sources, including plants, bacteria, animals, or synthetic production, and their effects and safety can vary greatly.
Because peptide therapy covers a broad range of products and claims, patients should ask their healthcare team what specific peptide therapy is being discussed, its purpose, and the evidence behind it. This helps avoid confusion and ensures safe, coordinated care.
Peptide therapy does not guarantee a cure or replacement for standard cancer treatments. Many claims about peptides curing cancer, detoxifying the body, or repairing DNA are not supported by strong evidence. Peptide therapies should be viewed cautiously, especially when offered outside of conventional medical settings or clinical trials.
Cancer patients often have special health concerns such as immune suppression, bleeding risks, organ problems, or drug interactions. Peptide therapies can interact with chemotherapy, radiation, immunotherapy, and other medications. Because of this, it is very important to discuss any peptide therapy with healthcare providers who understand the patient’s full medical situation before starting treatment.
If you hear about peptide therapy in your care, ask your healthcare team what it means for your specific diagnosis and treatment plan. Understand the goals, benefits, risks, and evidence level of the therapy. Never start peptide treatments without medical guidance, especially if you are undergoing cancer treatment. Your care team can help you decide if peptide therapy fits safely and effectively into your overall care.